Bank of Nova Scotia
ETON icon

Bank of Nova Scotia’s Eton Pharmaceutcials ETON Stock Holding History

Bank of Nova Scotia’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$365K Buy
+15,000
New +$262K ﹤0.01% 971

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Bank of Nova Scotia's ETON Position: Q1 2026 in Review

Bank of Nova Scotia opened a new position in Eton Pharmaceutcials (ETON) in Q1 2026: 15,000 shares worth $365K. The stake represents ﹤0.01% of the portfolio and ranks #971 among its holdings.

116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Bank of Nova Scotia held 15,000 shares of Eton Pharmaceutcials worth $365K as of Q1 2026.
  • Eton Pharmaceutcials was a new Bank of Nova Scotia position in Q1 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #971 holding.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.